Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients.
about
Immune-related adverse events with immune checkpoint inhibitors in thoracic malignancies: focusing on non-small cell lung cancer patients.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Immune-related adverse events ...... all cell lung cancer patients.
@en
Immune-related adverse events ...... all cell lung cancer patients.
@nl
type
label
Immune-related adverse events ...... all cell lung cancer patients.
@en
Immune-related adverse events ...... all cell lung cancer patients.
@nl
prefLabel
Immune-related adverse events ...... all cell lung cancer patients.
@en
Immune-related adverse events ...... all cell lung cancer patients.
@nl
P2093
P2860
P356
P1476
Immune-related adverse events ...... mall cell lung cancer patients
@en
P2093
Jesús Corral
Jordi Remon
Noelia Vilariño
Noemi Reguart
P2860
P304
S1516-S1533
P356
10.21037/JTD.2017.12.52
P433
P577
2018-05-01T00:00:00Z